Advanz Pharma

ADVANZ PHARMA is a global pharmaceutical company headquartered in London, UK, specializing in the commercialization and distribution of specialty, hospital, and rare disease medicines. The company operates in over 90 countries, with direct commercial presence in more than 20 key markets across Europe, North America, and Australia. ADVANZ PHARMA’s business model is built on partnerships with biopharma and pharmaceutical development firms, allowing it to bring innovative therapies to patients who depend on critical and often hard-to-access treatments.

The company’s diverse product portfolio includes innovative medicines, specialty generics, biosimilars, and originator brands. These products span a wide range of therapeutic areas such as hepatology, gastroenterology, anti-infectives, critical care, endocrinology, oncology, central nervous system disorders, and rare diseases. ADVANZ PHARMA supports its global operations with a Centre of Excellence in Mumbai, India, and an extensive network of over 300 partners involved in production, development, licensing, and commercialization.

Driven by a commitment to entrepreneurship, speed, and integrity, ADVANZ PHARMA aims to be the partner of choice for specialty medicines in Europe, Canada, and Australia, continually investing in collaborations to broaden patient access and improve health outcomes.

Keywords: specialty pharmaceuticals, rare diseases, hospital medicines, generics, biosimilars, commercialization, global distribution, therapeutic areas, partnerships, innovation, Centre of Excellence, patient access, health outcomes